[Diagnostics and treatment of intraductal papillary mucinous pancreas neoplasm].

Autor: Khatkov IE; Loginov Moscow Clinical Scientific Center., Poroshina EG; Mechnikov North-Western State Medical University., Solovyeva OI; Mechnikov North-Western State Medical University., Tokareva TP; Mechnikov North-Western State Medical University., Vorobyev SL; National Center for Clinical Morphological Diagnostics., Bakulina NV; Mechnikov North-Western State Medical University.
Jazyk: ruština
Zdroj: Terapevticheskii arkhiv [Ter Arkh] 2023 Oct 11; Vol. 95 (8), pp. 686-691. Date of Electronic Publication: 2023 Oct 11.
DOI: 10.26442/00403660.2023.08.202340
Abstrakt: A clinical case of a 71-year-old patient with intraductal papillary mucinous neoplasia (IPMN) is presented. The diagnosis was established using endoscopic retrograde cholangiopancreatography, magnetic resonance imaging, computed tomography. Asymptomatic course, absence of pain syndrome, obstruction, exocrine and endocrine pancreatic failure, relatively satisfactory general health, but the presence of structural changes: an increase cyst in the head of the pancreas measuring 27×23 mm, expansion of the main pancreatic duct up to 13 mm raised doubts about the choice of treatment tactics, the need for surgical intervention. To exclude the risk of malignancy and the choice of treatment tactics, a fine-needle aspiration biopsy was performed, a cytological examination of the material, an expert opinion determined the scope of the surgical intervention. IPMN is a rather rare tumor of the pancreas. For a long time, IPMN flow "under the guise" of chronic pancreatitis. Depending on the type of degree of dysplasia and invasiveness of IPMN, the tactics of treatment and the volume of surgical intervention are determined. High-tech methods provide high information content in the diagnosis of IPMN. But only a morphological study allows you to determine the tactics of treatment.
Databáze: MEDLINE